Quote:In April 2017, anti-vaccine groups seemed to have finally gotten what amounted to the Holy Grail for their cause: an allegedly large-scale, peer-reviewed study showing the links between vaccines and autism among a large population of children.
Vaccine skeptic groups, who reject the wide body of scientific literature refuting that link between vaccines and autism, have long sought such a study, but they’ve been hampered by practical concerns, most notably the ethical implications of withholding vaccines from a large group of children.
Released to heavy promotional fanfare on anti-vaccine websites and social media, a 24 April 2017 study published by the Journal of Translational Science claimed to be that Grail. The study (titled “Pilot Comparative Study on the Health of Vaccinated and Unvaccinated 6- to 12-Year Old U.S. Children”) neatly solved the problem of withholding vaccines by surveying parents who had already chosen not to vaccinate their children.
Using an online survey of 415 mothers of homeschooled children, the study concluded that vaccines can increase the risk of neurological developmental disorders, particularly in cases of preterm birth.
The anti-vaccine website Age of Autism, which also helped raise money for the study, reported its findings in glowing terms:
As parents have long expected, the rate of autism is significantly higher in the vaccinated group, a finding that could shake vaccine safety claims just as the first president who has ever stated a belief in a link between vaccines and autism has taken office.
The only problem? The paper is a identical version of a paper briefly published in Frontiers in Public Health in 2016 before being disowned by the publisher. This Translational Science version, as well, was pulled from the website with some reports that it had been retracted as well. As of 18 May 2017, however, the study reappeared on that journal’s website with no public comment for why it was removed or returned.
https://www.snopes.com/news/2017/05/17/vaccine-study-autism/
As we will describe below, these de facto retractions and high level of scrutiny stem not from a conspiracy to silence work critical of the medical establishment, but from the myriad ethical, methodological, and quantitative problems inherent in the study and to the research group behind it.
In short, the study’s design was flawed from the start.
Problems With The Study’s Statistical Analyses
The authors then dressed up their flawed, potentially biased data set in the cheap Halloween costume of a statistically responsible study. No amount of statistics, however, will get around the fact that there were not enough people in the study to address the questions they claim to have investigated.
Only 47 children in the 666-person study had what the authors defined as a neurological developmental disorders (also called an NDD), an already broadly-defined category that includes multiple conditions. Despite this, viral blog posts reporting on this study repeatedly state that autism risk, specifically, was higher in the vaccinated population. What those headlines fail to convey is that such a claim rests entirely on the nine people in the study who were actually diagnosed with autism.
The grossly insufficient sample size is most apparent in the lack of precision in the final results. The authors use something called an “odds ratio” to present their analysis — a measure that compares the relative odds of two populations with differing medical histories (i.e. vaccinated versus unvaccinated) developing a certain medical condition (i.e. NDDs). When scientists use odds ratios, they give a measure of how precise the odds are — a range of uncertainty that can be thought of as, essentially, as a margin of error.
In the Mawson study, they claim (for example) that a preterm birth combined with a vaccination caused a 6.6-fold increase in the odds of a neurological condition or learning disability. This result, a remarkably large odds ratio, comes with a laughable amount of precision — a range from 2.8 to 15.5. That wide a range of possibility is a big red flag, and is representative of many of the associations documented in the study.
The reason there is a range of possible outcomes is because odds ratios are generally pushed through statistical models meant to untangle the competing influences of other factors in their data, isolating the specific effect of one risk factor on an outcome. This is a crucial step for Mawson et al, because a significant number of children included in the NDD pool were also born prematurely, which multiple studies have already robustly linked to NDDs.
The competing influence of preterm birth on NDDs is arguably the largest methodological hurdle for the researchers to get around. The authors needed to make crystal clear that the association between NDDs and vaccination holds without the influence of preterm birth, or else the study is meaningless. They claim to have done so, but provide next to no documentation on the specifics of that process.
Without explaining what they did exactly, they simply write that they used two statistical models to adjust for preterm birth and that the “second adjustment” showed that there was a) no relationship between preterm birth and NDDs and b) there remained a relationship between vaccination and NDDs.
That is quite a statement. The researchers’ claim that there is no association between preterm birth and NDDs flies in the face of long-established science linking the two. Anytime research that contradicts long-understood and scientifically documented relationships should be read with a critical eye toward the methods used. But that is almost impossible here, as the only documentation the authors offer of their methods is to say they carried out a variety of regressions using a statistical software program called SAS.
What makes this worse is that the authors did not explicitly offer a hypothesis or any statistical criteria prior to beginning the study. That makes their data vulnerable to confirmation bias, as it allows them to potentially slice and dice data in as many ways as they want and plug those data into a program to see if their desired results that pops out. This study’s small sample size undoubtedly compounds this possibility, as it increases the likelihood for chance associations that may be flashy, but are ultimately not reproducible.
In April 2017, anti-vaccine groups seemed to have finally
Top 10 Most Recent News Articles
Fosun Reaches New Heights in Hang Seng Sustainability
Fosun International's Sustainability Milestone Now, you don't often see a company's sustainability rating climbing the ladder like a homesick angel, but Fosun International just nailed it. On September 7, 2026, their Hang Seng Sustainability Rating bumped up a notch from AA- to AA+, now at an all-time high. It's the sort of financial footnote that grabs the attention....
Continue Reading
Europe's Largest Carbon Capture Facility Launches
A New Chapter in Industrial Decarbonization Today's not just your average ribbon-cutting ceremony; it's a landmark turn in our journey toward a cleaner Europe. Yara's Sluiskil plant in the Netherlands just fired up Europe's biggest carbon capture facility, marking a crucial pivot point in industrial decarbonization. We're talking about capturing a staggering 800,000 tons...
Continue Reading
ISO 45010: First Guidance for Menstruation, Menopause
Tackling Menstruation and Menopause in the Workplace Today, the International Organization for Standardization (ISO) has taken a bold step forward by launching ISO 45010—a groundbreaking standard aimed at addressing menstruation and menopause in the workplace. Millions endure these natural processes throughout their careers, yet structured policies to support them have...
Continue Reading
Mermaid Folklore Meets Revolution in New Short Film
A Sea Haunting Like No Other Ever feel like history's forgotten tales deserve a fresh spin? Well, this one's shaking it up! Hoyt Dwyer, an Atlanta filmmaker, flips the script on a lesser-known bit from the American Revolution. Yeah, we're talking about Hessian soldiers and sirens here. Just hang on to your hats because this ain't your typical historical retelling. A...
Continue Reading
Global Movement Urges Dr. Hak Ja Han's Release
Under the shadows of Manhattan's skyline, something more than a regular service took shape. The New Yorker Hotel hosted an impassioned gathering of the Family Federation for World Peace and Unification. These folks weren't just saying their prayers; they were making a call—loud and resonant—for the release of Dr. Hak Ja Han. The Power of Collective Voices Gathering in...
Continue Reading
Nuix Leverages AI for Transformative Legal Review
Nuix Unveils AI Innovations in Legal Review Diving headfirst into the evolving world of legal technology, Nuix has just rolled out some serious upgrades to its eDiscovery toolkit. By plucking AI right out of the data science ethers, they're not just dabbling in futuristic tech—they're planting generative AI at the heart of legal review on their SaaS platform, Nuix...
Continue Reading
Nutromics Welcomes Plaxco: Strategic Tech Leap Forward
Professor Plaxco’s Dynamic Role at Nutromics Some folks start their day with breakfast and coffee, but Nutromics is grabbing headlines by introducing Professor Kevin Plaxco as the new Chief Scientific Officer. This strategic shift, made public on September 7, 2026, signals Nutromics’ ambition to amplify its DNA-based sensing footprint. As they gear up to launch their...
Continue Reading
Aroa Biosurgery Reports Low Infection Rates: A Milestone
Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...
Continue Reading
York Space Systems Faces Class Action Over Misleading IPO
York Space Systems Under the Legal Spotlight Ever get that feeling when something just doesn’t sit right? Like a burr under the saddle, York Space Systems is now grappling with a class action lawsuit that's throwing a heap of shade on its recent moves. What’s at play? Bronstein, Gewirtz & Grossman, LLC, a law firm that seems to have a nose for corporate messes, has...
Continue Reading
CelluPro Earns Global Recognition with EXCiPACT Certification
Breaking New Ground with EXCiPACT Certification Here's a tale unfolding in the high-stakes world of biotechnology—CelluPro, a standout in cell culture media, just snagged the EXCiPACT™ certification. This isn't just some fancy plaque for the wall. It's a stamp of approval that screams reliability in the global biomanufacturing supply scene. Why This Certification...
Continue ReadingTop 5 Most Recently Viewed Articles
Man Group PLC Discloses Significant Stake in TI Fluid Systems
Man Group PLC's Strategic Investment Man Group PLC is making a significant impact in the investment world with its notable stake in TI Fluid Systems. This announcement not only emphasizes the company’s solid growth strategy but also showcases its dedication to investing in emerging markets. TI Fluid Systems is well-known for its innovative fluid systems tailored for the...
Continue Reading
GCM Grosvenor Achieves New Heights with 52-Week Stock Surge
GCM Grosvenor Stock Hits New 52-Week High In a remarkable display of market confidence, GCM Grosvenor's stock has recently soared, hitting a new 52-week high of $12.59. This impressive price mark signifies an uplift in investor interest and reflects the company’s enhanced market valuation. GCM Grosvenor, with a notable market capitalization of $2.37 billion, has been...
Continue Reading
Abaxx Technologies Secures $22 Million Through Strategic Financing
Abaxx Technologies Closes $22 Million Financing Abaxx Technologies Inc. (CBOE:ABXX) has successfully closed a non-brokered private placement financing, raising US$22 million. This strategic move comes from a significant investor and includes the issuance of 1,000,000 units priced at US$22 each. Each unit is composed of a common share and a warrant that grants the right to...
Continue Reading
Investigating Potential Shareholder Rights Violations
Overview of Shareholder Investigations In recent news, Halper Sadeh LLC, a prominent law firm advocating for investor rights, has launched investigations into several companies including Zuora, Inc. (NYSE: ZUO), Avid Bioservices, Inc. (NASDAQ: CDMO), and BurTech Acquisition Corp. (NASDAQ: BRKH). These investigations focus on potential breaches of fiduciary duties and...
Continue Reading
Upcoming Treasury Bond Auction Details for Investors
Important Details on the Upcoming Treasury Bond Auction On the horizon, there's an exciting opportunity for investors to partake in the upcoming Treasury Bond auction featuring the RIKB 27 0415 and RIKB 35 0917 series. This auction is set to take place with several important dates to note, all crucial for those looking to add these bonds to their portfolio. Understanding...
Continue Reading